Aflibercept for choroidal neovascularizations secondary to pseudoxanthoma elasticum: a prospective study
Sign Up to like & getrecommendations! Published in 2019 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-019-04551-4
Abstract: Purpose To evaluate the use of 2 mg intravitreal aflibercept for treatment of choroidal neovascularization (CNV) secondary to angioid streaks in patients with pseudoxanthoma elasticum (PXE). Methods In this 12-month prospective, open-label, uncontrolled, non-randomized interventional clinical… read more here.
Keywords: choroidal neovascularizations; aflibercept choroidal; pseudoxanthoma elasticum; neovascularizations secondary ... See more keywords